Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors - Concepedia

Concepedia

Publication | Closed Access

Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors

76

Citations

24

References

1996

Year

SureshK Sankhla, J. S. Nadkarni, Sanat N. Bhagwati

Journal of Neuro-Oncology

Neuro-oncologyLymphoid NeoplasiaCancer ImmunosurveillanceImmunotherapyMedicineImmunologyLymphokine-activated KillerTherapeutic VaccineImmune Checkpoint InhibitorCell TransplantationRadiation OncologyOncologyGliomaAdoptive Immunotherapy

References

	Year	Citations

Page 1